Presynaptic tyrosine availability in the phenylketonuric brain: a hypothetical evaluation

Area of Science:

• Biochemistry
• Neuroscience
• Metabolic Disorders

Background:

• Phenylketonuria (PKU) is a genetic disorder characterized by impaired phenylalanine metabolism.
• Hyperphenylalaninemia, a hallmark of PKU, can affect neurotransmitter synthesis.
• Tyrosine is a crucial precursor for catecholamines, including dopamine and norepinephrine.

Purpose of the Study:

• To compare central nervous system (CNS) tyrosine availability for catecholamine synthesis in individuals with and without hyperphenylalaninemia.
• To quantify the impact of reduced CNS tyrosine on catecholamine precursor availability in phenylketonuria.

Main Methods:

• Utilized measured effects of amino acids on synaptosomal tyrosine uptake.
• Analyzed published data on human CNS amino acid levels.
• Performed hypothetical calculations to estimate tyrosine availability.

Main Results:

• Calculations indicate an approximately two-fold reduction in CNS tyrosine availability in the hyperphenylalaninemic condition.
• This reduction in tyrosine availability is attributed solely to decreased CNS tyrosine levels.
• Synaptosomal tyrosine uptake is directly influenced by amino acid concentrations.

Conclusions:

• Hyperphenylalaninemia leads to a significant deficit in CNS tyrosine availability.
• Reduced tyrosine availability in PKU directly impacts the precursor pool for catecholamine synthesis.
• These findings underscore a critical neurochemical consequence of phenylketonuria.